Sarah L. Mcglasson
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study.
Journal: The Lancet. Rheumatology
Published: July 31, 2025
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank.
Journal: Nature communications
Published: July 24, 2024
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease.
Journal: Brain : a journal of neurology
Published: June 19, 2024
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol.
Journal: Wellcome open research
Published: November 14, 2023
Neuromyelitis optica in patients with increased interferon alpha concentrations.
Journal: The Lancet. Neurology
Published: August 16, 2019
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 12, 2018
Neurological Disease in Lupus: Toward a Personalized Medicine Approach.
Journal: Frontiers in immunology
Published: March 09, 2018
Rare variants of the 3'-5' DNA exonuclease TREX1 in early onset small vessel stroke.
Journal: Wellcome open research
Published: October 10, 2017
Human β-defensin 3 increases the TLR9-dependent response to bacterial DNA.
Journal: European journal of immunology
Published: November 08, 2016
Detection of interferon alpha protein reveals differential levels and cellular sources in disease.
Journal: The Journal of experimental medicine
Published: August 31, 2016
Last Updated: 09/26/2026